Patent Assignment
Reel/Frame 047552/0613
Assignment of Assignor's Interest
Recorded: 2018-11-20
Pages: 6
Assignors
QUINN, JOHN FREDERICK
Executed: 2013-07-09
DUFFY, BRYAN CORDELL
Executed: 2013-07-12
LIU, SHUANG
Executed: 2013-07-12
WANG, RUIFANG
Executed: 2013-07-12
JIANG, MAY XIAOWU
Executed: 2013-07-12
MARTIN, GREGORY SCOTT
Executed: 2013-07-12
WAGNER, GREGORY STEVEN
Executed: 2013-07-26
YOUNG, PETER RONALD
Executed: 2013-07-10
Assignee
RVX THERAPEUTICS INC.
279 MIDPARK WAY SE, CALGARY, AB, T2X 1M2, CANADA
Covered Property
(1)
Novel Bicyclic Bromodomain Inhibitors
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
General Conveyance and Assumption Agreement
Nov 20, 2018
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP,
Reel/Frame 047605/0756 →
Assignment of Assignor's Interest
Nov 20, 2018
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 047605/0785 →
Change of Name
Nov 20, 2018
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 048148/0718 →
Assignment of Assignor's Interest
Nov 20, 2018
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 048148/0736 →